Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel steroid compounds demonstrate anticancer potential

Dec. 27, 2000

SLIL designs conformationally restricted polyamine analogues for cancer therapy

Dec. 27, 2000

New oncolytic drugs from Schering-Plough act by inhibiting protein farnesyltransferase

Dec. 22, 2000

Recent patent covers new GnRH antagonists prepared by Merck scientists

Dec. 22, 2000

Preclinical trials with decitabine suggest potential in myelodysplastic syndrome, multiple myeloma

Dec. 22, 2000

Potent, selective proteasome compounds derived from belactosin

Dec. 22, 2000

York Medical changes name, reports pipeline progress

Dec. 22, 2000

Protein farnesyltransferase inhibitors useful for cancer therapy patented by BMS

Dec. 21, 2000

Faslodex highlighted at Breast Cancer Symposium as a novel approach to postmenopausal breast cancer

Dec. 21, 2000

Results from ongoing phase II trial of 9-NC in metastatic breast cancer reported in San Antonio

Dec. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...